Shares movie streaming and DVD rental Company Netflix Inc. (NASDAQ: NFLX) climbed about 5.60% by afternoon trade after analysts at at B. Riley & Co upgraded the stock from “sell” to “buy” rating, and boosted the price target on the stock to $165 from $90. Earlier on April 15, another equity research firm BS AG initiated the coverage of the stock with a “buy” rating and set a price target of $250.0 a share.
Continue reading Major Movers on April 22; NFLX, BIIB, SIX, NVR, HAL
Shares of Five Below Inc. (NASDAQ: FIVE) slumped in early trade after the discount retailer, which focuses on teenagers and preteen consumers, late last evening, provided downbeat guidance on the current fiscal year. However, fiscal fourth quarter results edged past analysts’ estimations.
Continue reading Major Movers on March 28; FIVE, PVH, BBRY, BIIB
Shares of Biogen Idec Inc. (NASDAQ: BIIB) gained in premarket hours on Thursday after the FDA said late on Wednesday that it has approved the biotechnology Company’s new multiple sclerosis drug, Tecfidera.
Continue reading FDA Approves Biogen Idec’s Potential Blockbuster Treatment for MS (BIIB)
Shares of Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology company, have risen sharply in early trading today after the Weston, Massachusetts-based company reported its fourth-quarter and full-year 2012 financial results.
Continue reading Biogen Idec Shares Rise Sharply on Q4 Results (BIIB)